Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBK1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | APOE | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | COL5A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | MARVELD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | APEH | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ZFAND4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | DMTN | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CCL5 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | HDDC2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | BIRC5 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |